Catalent to Acquire Cook Pharmica for $950 Million
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Catalent (CTLT) PT Raised to $45 at BofA/Merrill Lynch Following Announced Plans to Acquire Pharmica
September 20, 2017 9:19 AM EDTBofA/Merrill Lynch raised its price target on Catalent (NYSE: CTLT) to $45.00 (from $40.00) while maintaining a Buy rating following the company's announced its intention to acquire Cook Pharmica for $950 in cash. CTLT expects the incremental free cash flow generation to assist in deleveraging,... More
